Marketing at the Point of Care: Assisting Patients with Rare Diseases in Discovering Appropriate Treatment.
POINT OF CARE MARKETING: Helping Rare Disease Patients Find the Right Care In the increasingly complex landscape of healthcare, finding the right care can be a daunting task, especially for patients dealing with rare diseases. These individuals often face a long and challenging journey, navigating through a maze of symptoms, specialists, and potential treatments. Point […]
Calcium+Company Unveils Bruno Brasileiro as New Chief Creative Officer.
Calcium+Company Announces New Chief Creative Officer, Bruno Brasileiro In a significant move signaling a fresh direction in creative leadership, Calcium+Company has officially appointed Bruno Brasileiro as its new Chief Creative Officer. This strategic hire aims to leverage Brasileiro’s extensive expertise to invigorate the company’s creative capabilities and drive innovation across its portfolio. With a proven […]
STAT+: Daily Summary of ASCO: Novartis Myelofibrosis Treatment Safety Information and Survival Results for Pfizer Medication.
ASCO Daily Roundup: Latest on Novartis and Pfizer Developments The American Society of Clinical Oncology (ASCO) annual meeting, a pivotal venue for showcasing breakthroughs and updates in cancer treatment, has delivered compelling updates regarding noteworthy pharmaceutical advancements. Two major highlights from the latest sessions include the revelation of safety data for a promising Novartis candidate […]
STAT+: HHS Allows Change Healthcare to Issue Data Breach Notifications on Behalf of Hospitals
HHS Allows Change Healthcare to Issue Data Breach Notifications on Behalf of Hospitals In a landmark decision, the Department of Health and Human Services (HHS) has granted Change Healthcare, a major player in the healthcare technology sector, the authority to issue data breach notifications directly to patients on behalf of hospitals. This unprecedented move aims […]
FDA personnel highlight deficiencies in Lykos data on MDMA treatment.
FDA Staff Outline Shortcomings of Lykos Data for MDMA Therapy In a recent analysis, staff from the U.S. Food and Drug Administration (FDA) have drawn attention to several significant shortcomings in the data provided by Lykos Pharmaceuticals regarding the use of MDMA (3,4-Methylenedioxymethamphetamine) for therapeutic purposes. The critical examination of the submitted data has raised […]
STAT+: Novartis files a lawsuit against Maryland regarding the involvement of contract pharmacies in an American medication discount scheme.
Novartis Challenges Maryland Over Contract Pharmacy Regulations in U.S. Drug Discount Program In a significant legal action that underscores the ongoing tensions between pharmaceutical giants and state regulations, Novartis has initiated a lawsuit against the state of Maryland. The contention at the heart of the legal battle revolves around the role of contract pharmacies within […]
Immunovant alters strategy for highly anticipated autoimmune medications.
Immunovant Revamps Strategy for Highly Anticipated Autoimmune Medications In a significant shift that has caught the attention of the biotechnology industry, Immunovant, a biopharmaceutical company with a keen focus on innovative treatments for autoimmune diseases, has announced changes in its development plans for its promising pipeline of autoimmune medications. This move represents a dramatic turn […]
Clinical Laboratory Association Files Lawsuit Against FDA Regarding Regulation of In-House Developed Tests
Clinical Lab Trade Group Initiates Legal Action Against FDA Over Proposed Regulation of Lab-Developed Tests In a significant legal challenge to the U.S. Food and Drug Administration (FDA), a leading trade association representing clinical laboratories has filed a lawsuit against the agency over its plans to regulate lab-developed tests (LDTs). This move marks a pivotal […]
A biotech firm developing an innovative IVF technique secures $33 million in new capital.
Revolutionizing IVF: Innovative Biotech Secures $33M in Fresh Funding In an impressive stride towards changing the landscape of reproductive medicine, a groundbreaking biotech firm has recently closed a $33 million funding round. This infusion of capital is earmarked for the development and refinement of a novel approach to in vitro fertilization (IVF) technology. The ambitious […]
Association between heat waves and higher preterm birth risk in the U.S.
Rising Temperatures, Rising Risks: The Link Between Heat Waves and Preterm Births in the U.S. Understanding the Connection In recent studies, a concerning correlation between heat waves and an increase in preterm birth rates in the United States has come to light. As global temperatures continue to climb, the impact on pregnant individuals and their […]